This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Brookdale May Not Be a Safe Bet Despite 34-Month Occupancy Growth
by Zacks Equity Research
Rising operating costs due to inflationary challenges in the senior living industry and higher estimated insurance expenses are likely to keep BKD's margins under pressure.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Breaking Down Common Investing Strategies
by Derek Lewis
Income investors seek steady payouts, growth investors seek companies expected to grow at an above-average pace, and value investors seek deals hidden in plain sight.
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
by Zacks Equity Research
The latest trading day saw Tenet Healthcare (THC) settling at $154.62, representing a +0.91% change from its previous close.
Here's Why Universal Health Shares are Attracting Investors Now
by Zacks Equity Research
UHS remains well-poised for growth on improved patient days at its behavioral healthcare facilities, acquisitions and solid cash flows.
Should Vanguard S&P Mid-Cap 400 Value ETF (IVOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOV
Here's How Much You'd Have If You Invested $1000 in Tenet Healthcare a Decade Ago
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Elevance Health Stock Has More to Offer: Should You Hold on Tight?
by Zacks Equity Research
In the commercial category, an increase in individual as well as employer group fee-based memberships will continue supporting ELV's medical membership numbers.
Ensign Adds 8 Facilities in Kansas & Colorado to Expand Footprint
by Zacks Equity Research
The acquisition deals increase ENSG's portfolio to encompass 323 healthcare operations spanning 14 states.
Encompass Health Stock Rises 39.4% YTD: Should You Buy Now?
by Zacks Equity Research
To meet the increasing demand for its services, EHC is expected to continue adding beds.
Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Humana (HUM), Evergreen Nephrology Partner to Improve Health Outcomes
by Zacks Equity Research
HUM collaborates with Evergreen Nephrology to introduce a specialized care program for chronic kidney disease patients.
Centene Shifts an AcariaHealth Facility to Shelby Township
by Zacks Equity Research
The relocation of the facility is expected to enhance CNC's specialty pharmacy capabilities and patient care services.
Why Is Acadia Healthcare (ACHC) Up 9.1% Since Last Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should iShares S&P Mid-Cap 400 Value ETF (IJJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJJ
Tenet Stock Rises 24.6% in 3 Months: Is This Your Buy Signal?
by Kaibalya Pravo Dey
Despite the recent growth in stock price, THC is trading at a discount compared to the industry average.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare (THC) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Brokers Suggest Investing in Tenet (THC): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Tenet (THC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Ensign Group (ENSG) Up 50% in Past Year: More Growth on the Horizon?
by Zacks Equity Research
Ensign Group (ENSG) remains well-poised for growth on the back of improved skilled services revenues, higher rental revenues and adequate operating cash flows.
Why Is Tenet (THC) Up 7.2% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Can U.S. Stocks Rally After Chair Powell Speaks?
by John Blank
Less uncertainty is usually a benefit.